Home » VERTEX PHARMACEUTICALS AND CYSTIC FIBROSIS FOUNDATION THERAPEUTICS ENTER COLLABORATION
VERTEX PHARMACEUTICALS AND CYSTIC FIBROSIS FOUNDATION THERAPEUTICS ENTER COLLABORATION
Vertex Pharmaceuticals Incorporated and Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT) today announced that they have entered into a new collaboration to accelerate clinical development of VX-770, a novel, oral drug candidate for the treatment of cystic fibrosis (CF). CFFT is the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation.
CNW Group (http://www.newswire.ca/en/releases/archive/March2006/23/c5167.html)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
07May
-
14May
-
30May